Reporting on a recent discovery by the Israeli company Compugen of eight novel GPCR peptide ligands, Keith Robison ponders G-protein coupled receptors. Check out his blog, Omics! Omics!, where he discloses quite a bit of information on the types of GPCR ligands, and the inherent difficulty in screening for small molecule drug candidates.